
Apretude (Cabotegravir)
APRETUDE is indicated in at-risk adults and adolescents weighing at least 35 kg for pre‑exposure prophylaxis (PrEP) to reduce the risk of sexually acquired HIV-1 infection. Individuals…
APRETUDE is indicated in at-risk adults and adolescents weighing at least 35 kg for pre‑exposure prophylaxis (PrEP) to reduce the risk of sexually acquired HIV-1 infection. Individuals…
CABENUVA is indicated as a complete regimen for the treatment of HIV-1 infection in adults and adolescents 12 years of age and older and weighing at least 35 kg to replace the current…
COMBIVIR, a combination of 2 nucleoside analogues, is indicated in combination with other antiretrovirals for the treatment of human immunodeficiency virus type 1 (HIV‑1) infection…
DOVATO is indicated as a complete regimen for the treatment of HIV-1 infection in adults with no antiretroviral treatment history or to replace the current antiretroviral regimen in those…
EPIVIR is a nucleoside analogue indicated in combination with other antiretroviral agents for the treatment of human immunodeficiency virus type 1 (HIV‑1) infection. Limitations of Use:…
As the leading independent provider of trustworthy medication information, we source our database directly from the FDA's central repository of drug labels and package inserts under the Structured Product Labeling standard. Our material is not intended as a substitute for direct consultation with a qualified health professional.
Terms of Use | Copyright © 2023. All Rights Reserved.